Rajesh C. Shrotriya

2013

In 2013, Rajesh C. Shrotriya earned a total compensation of $5.6M as Chairman and Chief Executive Officer at Spectrum Pharmaceuticals, a 44% decrease compared to previous year.

Compensation breakdown

Bonus$900,000
Option Awards$2,929,657
Salary$900,000
Stock Awards$734,400
Other$167,508
Total$5,631,565

Shrotriya received $2.9M in option awards, accounting for 52% of the total pay in 2013.

Shrotriya also received $900K in bonus, $900K in salary, $734.4K in stock awards and $167.5K in other compensation.

Rankings

In 2013, Rajesh C. Shrotriya's compensation ranked 1,073rd out of 12,286 executives tracked by ExecPay. In other words, Shrotriya earned more than 91.3% of executives.

ClassificationRankingPercentile
All
1,073
out of 12,286
91st
Division
Manufacturing
346
out of 4,614
93rd
Major group
Chemicals And Allied Products
91
out of 1,466
94th
Industry group
Drugs
56
out of 1,160
95th
Industry
Pharmaceutical Preparations
50
out of 890
94th
Source: SEC filing on April 29, 2016.

Shrotriya's colleagues

We found five more compensation records of executives who worked with Rajesh C. Shrotriya at Spectrum Pharmaceuticals in 2013.

2013

Kurt Gustafson

Spectrum Pharmaceuticals

Chief Financial Officer

2013

Joseph Keller

Spectrum Pharmaceuticals

Chief Operating Officer

2013

Lee Allen

Spectrum Pharmaceuticals

Chief Medical Officer

2013

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Operating Officer

2013

Brett Scott

Spectrum Pharmaceuticals

Senior Vice President, Finance

In-depth

You may also like